Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT).

[1]  C. Lorson,et al.  SMN oligomerization defect correlates with spinal muscular atrophy severity , 1998, Nature Genetics.

[2]  D. Rubinsztein,et al.  Functional analysis of the Huntington's disease (HD) gene promoter. , 1998, Human molecular genetics.

[3]  J. Ikeda,et al.  Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP. , 1998, Genomics.

[4]  T. Saito,et al.  Molecular Variation of the Human Angiotensinogen Core Promoter Element Located between the TATA Box and Transcription Initiation Site Affects Its Transcriptional Activity* , 1997, The Journal of Biological Chemistry.

[5]  L. Surh,et al.  Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7 , 1997, Neurogenetics.

[6]  J. Mendell,et al.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. , 1997, American journal of human genetics.

[7]  B. Dallapiccola,et al.  Expression study of survival motor neuron gene in human fetal tissues. , 1997, Biochemical and molecular medicine.

[8]  B. Wirth,et al.  Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). , 1997, Human molecular genetics.

[9]  C. Ponting,et al.  Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? , 1997, Human molecular genetics.

[10]  J. Melki,et al.  Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. , 1996, Human molecular genetics.

[11]  D. Parsons,et al.  An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. , 1996, Human molecular genetics.

[12]  A. Munnich,et al.  Structure and organization of the human survival motor neurone (SMN) gene. , 1996, Genomics.

[13]  A. Munnich,et al.  A frame–shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients , 1995, Nature Genetics.

[14]  B. Dallapiccola,et al.  Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. , 1995, Biochemical and biophysical research communications.

[15]  T. Crawford,et al.  The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy , 1995, Cell.

[16]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[17]  T. Crawford,et al.  A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients , 1995, Nature Genetics.

[18]  J. McPherson,et al.  Association between Ag1-CA alleles and severity of autosomal recessive proximal spinal muscular atrophy. , 1994, American journal of human genetics.

[19]  D. Le Paslier,et al.  De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. , 1994, Science.

[20]  J. McPherson,et al.  A multicopy dinucleotide marker that maps close to the spinal muscular atrophy gene. , 1994, Genomics.

[21]  T. Munsat,et al.  International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany) , 1992, Neuromuscular Disorders.

[22]  H. Kim,et al.  Embryonic mouse spinal cord motor neuron hybrid cells. , 1991, Neuroreport.

[23]  A. Czeizel,et al.  A hungarian study on Werdnig-Hoffmann disease. , 1989, Journal of medical genetics.

[24]  J. Pearn.  CLASSIFICATION OF SPINAL MUSCULAR ATROPHIES , 1980, The Lancet.

[25]  J. Pearn.  The Gene Frequency of Acute Werdnig-Hoffmann Disease (SMA Type 1). A Total Population Survey in North-East England , 1973, Journal of medical genetics.

[26]  D. F. Roberts,et al.  The Genetic Component in Child Mortality , 1970, Archives of disease in childhood.